About Boditech Med
Boditech Med is a publicly listed company based in Chuncheon (South Korea) founded in 1998. Developing in vitro diagnostics analyzer instruments and reagents. The company has 532 employees. Boditech Med has completed 1 acquisition, including Immunostics. Its website boditech.co.kr draws about 21 thousand monthly visits. Its Indian entity Boditech Med India Private Limited reported revenue of ₹8.19 Cr. Boditech Med offers products and services including ichroma™ Diagnostic Kits and AFIAS Diagnostic Analyzer. Its focus areas include Diversified Diagnostics.
Company details
Boditech is focussed on developing in vitro diagnostics instruments and reagents. It is primarily developing two products ichroma, a portable fluorescence scanning instrument for measuring the concentration of target analytes in human blood, urine and other specimens which will be properly processed in accordance with the appropriate Immunoassay Test procedures and hemochroma plus, a hand-held device to measure the concentration of total hemoglobin in the blood. It is also working on a wider range of diagnostic biomarkers and automated analyzers. The available tests include cardiac markers, HbA1c, Tumor markers, microalbumin, infection, rheumatoid arthritis, Vitamin D, and Ferritin.
- Headquarters Chuncheon, South Korea
- Employees 532
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website boditech.co.kr/en
- Social LinkedIn X Facebook YouTube
- Legal Name Boditech Med, Inc.
- Indian entity revenue₹8.19 Cr
FY 2025 · +65% YoY
- Indian entity net loss-₹65.8 Lakh
FY 2025 · -8% margin
- Indian entity EBITDA-₹66.2 Lakh
FY 2025 · -8% margin
- Latest Funding Round$13.22M (USD), Post-IPO
Apr 2017
- Investors
- Employee Count532
- Investments & Acquisitions
Associated legal entities of Boditech Med
Boditech Med operates through Boditech Med India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Boditech Med India Private Limited CIN U33100MH2021FTC358794 | Active | 12 Apr 2021 | Mumbai, Maharashtra | ₹8.2 Cr | 4 | View details |
Products & Services of Boditech Med
Boditech Med offers a comprehensive portfolio of products and services, including ichroma™ Diagnostic Kits and AFIAS Diagnostic Analyzer.
Kits for rapid detection of infectious diseases like dengue
Automated analyzer for blood sample testing in diagnostics
Apps and channels of Boditech Med
its YouTube channel Boditech Med Inc. has 8.29K subscribers and 30 videos.
Videos from Boditech Med
The most watched videos on Boditech Med's YouTube channel, Boditech Med Inc. (8.29K subscribers). Click a video to play it here.
More on Boditech Med Inc..
Funding Insights of Boditech Med
- Total Rounds 1
- Last Round Post-IPO — $13.22M
- First Round $13.22M
(Apr 2017)
- Investors Count 1
All 1 funding rounds of Boditech Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | $13.22M | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Boditech Med
Boditech Med has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DAOL Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund | daolinvestment.com | Seongnam-si, South Korea |
Investor details for Boditech Med
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Boditech Med India Private Limited (Boditech Med)
Boditech Med India Private Limited is the primary company behind Boditech Med. The board of Boditech Med India Private Limited currently have 3 directors; the longest-serving is Laxmi Narshima Prasad Ambati, appointed in 2021. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Laxmi Narshima Prasad Ambati DIN 09143448 | Director | 12 Apr 2021 | 5 yrs 6 mo | Boditech Med India Private Limited |
| Hee Jae Park DIN 09143449 | Director | 12 Apr 2021 | 5 yrs 6 mo | Boditech Med India Private Limited |
| Ook Sung Ha DIN 11158995 | Additional Director | 18 Jun 2025 | 1 yr 4 mo | Boditech Med India Private Limited |
IPO & Listings of Boditech Med
Boditech Med is a publicly listed company on the KRX with ticker symbol 206640 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Dec 2014
- Listed onKRX: 206640
- Listed entityBoditech Med, Inc.
- Exchange sectorHealth technology
- ISINKR7206640005
- Share price9,390.00 KRW (-0.21% on the day) · 2026-10-14
- Market capitalisation191,446,282,005.00 KRW
- Price to earnings7.8
- EPS (diluted, trailing year)1,197.03 KRW
- Dividend yield1.59%
- Volume (last session)18,995
Financials of Boditech Med
Figures of Boditech Med India Private Limited, the primary company behind Boditech Med, for FY 2025. Revenue was ₹8.19 Cr (+65% year on year). Net loss was -₹65.8 Lakh (-8% margin). EBITDA was -₹66.2 Lakh (-8% margin). Revenue has grown at a compounded annual rate of +137% over three years.
- ₹8.19 CrRevenue · FY 2025 · +65% YoY
- -₹65.8 LakhNet loss · -8% margin
- -₹66.2 LakhEBITDA · -8% margin
- ₹43.36 CrPaid-up capital
- +137%Revenue CAGR, 3 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 162.09B KRW | 23.65B KRW | 37.87B KRW |
| 2024 | 138.16B KRW | 27.26B KRW | 34.57B KRW |
| 2023 | 134.22B KRW | 25.95B KRW | 35.01B KRW |
| 2022 | 118.08B KRW | 24.15B KRW | 30.79B KRW |
| 2021 | 157.71B KRW | 44.37B KRW | 56.68B KRW |
Balance sheet, profit and loss, cash flow and ratios of Boditech Med India Private Limited are on its company page.
Detailed financial statements for Boditech Med
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boditech Med
Boditech Med has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Immunostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Rapid diagnostic tests, kits, and reagents for diseases are developed. | immunostics.com | Ocean Township, United States | 1983 | Mar 2016 | $13.63M |
Complete acquisition details for Boditech Med
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Boditech Med
4 dated milestones of Boditech Med across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Boditech Med is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Immunostics.
- Funding First funding round of $13.2M.
Web traffic of Boditech Med
The website of Boditech Med (boditech.co.kr) receives about 21.1K visits a month.
- Monthly visits21.1K
▲ 22.9% vs previous month
Websites whose visitors overlap most with Boditech Med. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| i-sens.com | 100% | 63.3K | #435,314 | View details | |
linear.es | linear.es | 100% | #1,370,338 | – | |
biolaboratorio.com | biolaboratorio.com | 88% | – | ||
medicalproductguide.com | medicalproductguide.com | 86% | – | ||
kmdia.or.kr | kmdia.or.kr | 85% | #207,327 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Boditech Med
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Boditech Med
Complete news archive for Boditech Med
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boditech Med
Boditech Med was founded in 1998 and raised its 1st funding round 19 years after it was founded.
Boditech Med is headquartered in Chuncheon, South Korea. It is registered at Chuncheon, Gangwon, South Korea.
Boditech Med has 532 employees.
The primary company behind Boditech Med, Boditech Med India Private Limited, reported revenue of ₹8.19 Cr for FY 2025, up 65% year on year.
Boditech is focussed on developing in vitro diagnostics instruments and reagents. It is primarily developing two products ichroma, a portable fluorescence scanning instrument for measuring the concentration of target analytes in human blood, urine and other specimens which will be properly processed in accordance with the appropriate Immunoassay Test procedures and hemochroma plus, a hand-held device to measure the concentration of total hemoglobin in the blood. It is also working on a wider range of diagnostic biomarkers and automated analyzers. The available tests include cardiac markers, HbA1c, Tumor markers, microalbumin, infection, rheumatoid arthritis, Vitamin D, and Ferritin.
Boditech Med offers ichromaâ„¢ Diagnostic Kits and AFIAS Diagnostic Analyzer.
Yes, Boditech Med is publicly traded on KRX under the ticker symbol 206640.
Boditech Med has made 1 acquisition, including Immunostics.
Boditech Med has 1 investor. Key investors include DAOL Investment.
Boditech Med operates through Boditech Med India Private Limited.
The legal entities of Boditech Med currently have 4 directors, including Laxmi Narshima Prasad Ambati, Hee Jae Park, Ook Sung Ha and others.